The TFA Cannula incorporates a distal balloon feature designed to allow blood flow to the cannulated limb during cardiopulmonary bypass
VANCOUVER, BC, July 30, 2026 /CNW/ — Total Flow Medical, a medical device company developing solutions for extracorporeal circulation, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Total Flow Medical Femoral Arterial (TFA) Cannula, a femoral arterial cannula indicated for extracorporeal circulation during cardiopulmonary bypass procedures for up to six hours. The device incorporates a balloon at its distal tip designed to allow blood flow to the cannulated limb.